Back |
home / stock / cnvcf / cnvcf message board
Subject | By | Source | When |
---|---|---|---|
$CNVCF BioHarvest Sciences Inc. 2021 CEO Letter to | AskMuncher | investorshub | 01/01/2022 5:13:05 PM |
I do not know if this has been | happyglass | investorshub | 12/31/2021 5:46:04 AM |
I vote with my dollar for a better | happyglass | investorshub | 12/30/2021 3:58:35 AM |
My last post has a mistake..I mentioned a | Farmpride | investorshub | 12/30/2021 12:06:39 AM |
The only thing I have found that comes | Farmpride | investorshub | 12/29/2021 9:28:12 AM |
I have been in the legal cannabis space | happyglass | investorshub | 12/15/2021 3:55:17 AM |
My fav. Holding...to me this is the sleeper | Farmpride | investorshub | 11/08/2021 9:34:12 PM |
$CNVCF BioHarvest Sciences Inc. Announces Appointment of David | AskMuncher | investorshub | 10/24/2021 10:59:04 AM |
$CNVCF BioHarvest Sciences Inc. Increases Its VINIA 2021 | AskMuncher | investorshub | 10/14/2021 5:29:54 PM |
Thank you Renee | Augustwd | investorshub | 04/23/2020 5:33:25 PM |
Canna-V-Cell Sciences Inc. changed to Bioharvest Sciences Inc.: | Renee | investorshub | 04/22/2020 9:41:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Canna-V-Cell Sciences Inc Company Name:
CNVCF Stock Symbol:
OTCMKTS Market:
Canna-V-Cell Sciences Inc Website:
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host ...
--News Direct-- BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share the company's impressive financial and operational results for the fourth quarter and full year ended December 31, 2023. Revenue surged by 131% to $12.7 million in 2023, compared to $5.5 millio...
FY 2023 Revenue Increased 2.3x to $12.7 Million USD The Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 million Management pursuing Nasdaq listing by end of year. General and Special meeting called to ...